Outcome Statistics

This page presents our outcomes in graphic form.  Please refer to the Case Studies page for information regarding the treatment response and course of our first 25 patients.

Group Results - First 300 Female and First 130 Male Patients to complete an Initial Course of Modified hCG Therapy 
                  

Weight Loss by Female and Male Treatment Groups (30 Female and 10 Male Patients per Group)   
                                                                                                                                                       

                                              
                                        One Hundred Female Patients who have completed Two Courses of Modified hCG Therapy
                                     Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                      Some patients were less adherent to the protocol during round two and many utilized the 26 day protocol - their results are included. their                                                                                                                                                             

 

                                             Ten Female Patients who have completed Three Courses of Modified hCG Therapy
                                     Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                      Some patients were less adherent to the protocol during round two and/or utilized the 26 day protocol - their results are included. the

                                             Thirty Four Male Patients have completed Two Courses of Modified hCG Therapy
                                            Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                   Some patients were less adherent to the protocol during round two and/or utilized the 26 day protocol - their results are included. the                                                                                                                    

First Ten Female Patients who have completed an Initial Course of Modified hCG Therapy             

First Ten Male Patients who have completed an Initial Course of Modified hCG Therapy

Fourteen Women and Eight Men have completed a 23 Day Initial Course of Modified hCG Therapy    

Second Ten Male Patients who have completed an Initial Course of Modified hCG Therapy    

                  
            Second Ten Female Patients who have completed an Initial Course of Modified hCG Therapy                                         

    
      Third Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy 

 
Third Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy                              

Fourth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy      

Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Fifth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

Fifth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Sixth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy
       

Seventh and Eighth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

Ninth and Tenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

Seventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Ninth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Eleventh and Twelfth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

Thirteenth and Fourteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

Tenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Eleventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Twelfth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Thirteenth and Fourteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Fifteenth and Sixteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Seventeenth and Eighteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Nineteenth and Twentieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Twenty First and Twenty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Twenty Third and Twenty Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Twenty Fifth and Twenty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Twenty Seventh and Twenty Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Twenty Ninth and Thirtieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Thirty First and Thirty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Patients with Limited Adherence to the Diet   

      Most of our patients followed the diet to the letter - and then were rewarded with a significant weight loss.  Others followed the diet most of the time, breaking away occasionally in relation to hunger or social obligations (we are all human); their statistics are included in the overall results.  The vast majority of our patients completed a 40 day program.  The 26 day patients are not included in the above statistics.  Also excluded from the main statistics and presented below are patients who did not follow the program most of the time.  As you can see, when you do not follow Dr. Simeons' guidelines you do not obtain a significant reduction in weight. 

Early Discontinuation
A small number of patients (»10% of those who start) stopped early or dropped out of the program for the reasons given below.

      Patients who dropped out or stopped early did so primarily due to loss of motivation and/or hunger.  We did not feel that the hCG program was the cause of M1dc's prostatitis, M3dc's disc disease flare up, M8dc's diverticular disease, or M2dc's upper respiratory tract infection.  However, 10 days later M2dc experienced gall bladder inflammation, leading to cholycystectomy (surgical removal of the gall bladder).  W98 also required cholycystectomy towards the end of her 40 day program.  Rapid weight reduction by any means can lead to inflammation within the gall bladder (probably only in individuals with pre-existent gall bladder disease but we cannot say this with certainty).  Thus our gall bladder event rate is approximately 0.4% of patients treated.  Two patients experienced a transient flare up of gout.  These side-effects of hCG-assisted weight reduction are not unexpected and are discussed by Dr. Simeons in his book.  Two female patients experienced upper respiratory infections and stopped early; we feel this was the seasonal flu and not a direct complication of their weight loss program.  One patient who was doing well was diagnosed with an unrelated problem and had to drop out early.  A small number of patients developed urinary tract infection or pneumonia while on the program.  These infections are likely incidental to weight loss, and not caused by weight loss.  However, if significant infection occurs, we counsel you to stop hCG and immediately increase caloric intake to a Phase 3 level, emphasizing protein over carbohydrate, as 500 calories a day is not sufficient when your physiology is marshaling its resources to defend you against bacterial invasion.  The program can be restarted (including the gorge days) after you have recovered.   

                                                                                                               Current Status (as of 7/30/10)

      Please Note -  It is the position of the FDA and FTC that HCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity.  There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes more attractive or “normal” distribution of fat, or that it decrease the hunger and discomfort associated with calorie-restricted diets.